Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial – Reuters

AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca’s blockbuster lung cancer …

Share on Facebook

Tweet

Follow us

Save